Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification

Bibliographic Details
Title: Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
Authors: Sunyoung Jung, Sunho Lee, Hyun Je Kim, Sueon Kim, Ji Hwan Moon, Hyunwoo Chung, Seong-Jun Kang, Chung-Gyu Park
Source: Experimental and Molecular Medicine, Vol 55, Iss 3, Pp 665-679 (2023)
Publisher Information: Nature Publishing Group, 2023.
Publication Year: 2023
Collection: LCC:Medicine
LCC:Biochemistry
Subject Terms: Medicine, Biochemistry, QD415-436
More Details: Abstract Mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEVs) are known to exert immunosuppressive functions. This study showed that MSC-sEVs specifically convert T helper 17 (Th17) cells into IL-17 low-producer (ex-Th17) cells by degrading RAR-related orphan receptor γt (RORγt) at the protein level. In experimental autoimmune encephalomyelitis (EAE)-induced mice, treatment with MSC-sEVs was found to not only ameliorate clinical symptoms but also to reduce the number of Th17 cells in draining lymph nodes and the central nervous system. MSC-sEVs were found to destabilize RORγt by K63 deubiquitination and deacetylation, which was attributed to the EP300-interacting inhibitor of differentiation 3 (Eid3) contained in the MSC-sEVs. Small extracellular vesicles isolated from the Eid3 knockdown MSCs by Eid3-shRNA failed to downregulate RORγt. Moreover, forced expression of Eid3 by gene transfection was found to significantly decrease the protein level of RORγt in Th17 cells. Altogether, this study reveals the novel immunosuppressive mechanisms of MSC-sEVs, which suggests the feasibility of MSC-sEVs as an attractive therapeutic tool for curing Th17-mediated inflammatory diseases.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2092-6413
Relation: https://doaj.org/toc/2092-6413
DOI: 10.1038/s12276-023-00949-7
Access URL: https://doaj.org/article/787e543b53354489b9d8a28a17b5418b
Accession Number: edsdoj.787e543b53354489b9d8a28a17b5418b
Database: Directory of Open Access Journals
More Details
ISSN:20926413
DOI:10.1038/s12276-023-00949-7
Published in:Experimental and Molecular Medicine
Language:English